Why quantum deserves a closer look now
The reason quantum is getting more interesting is not because the technology is suddenly mature. It is because the sector is finally starting to separate into three buckets: companies with actual customer traction, companies with credible scaling roadmaps, and companies with enough capital to keep building without immediately returning to the market for survival financing.
That matters. For years, quantum investing was mostly about hopes, patents, and PowerPoint. Now, investors can start underwriting more specific questions: Who has customers? Who has a believable roadmap? Who has enough cash? Who is building something that could matter before the decade is over? That is a much more serious conversation than the sector had even a year ago.
This is not one trade — it is three different quantum trades
One of the biggest mistakes investors make in quantum is treating all the names as interchangeable. They are not.
Some are trying to prove commercial use cases today. Some are trying to win the long-horizon architecture race. Others are trying to build around adjacent enabling technologies like photonics, sensing, and communications. If you do not separate those, you end up comparing the wrong things.
That is why these three names belong on the same list, but for very different reasons.
D-Wave is the most credible pure-play commercial story
If the goal is to own a smaller-cap quantum name with actual operating traction, D-Wave Quantum (NYSE: QBTS) is probably the cleanest case right now.
The headline number that matters is not the revenue miss. It is the bookings. D-Wave just reported Q1 2026 bookings of $33.4 million, up 1,994% year over year, including a $20 million system sale to Florida Atlantic University and a $10 million, two-year Quantum Computing as a Service deal with a Fortune 100 customer. It also ended the quarter with $588.4 million in cash and marketable investment securities and $42.4 million in remaining performance obligations.
That is why the stock remains interesting despite the ugly headline revenue comparison. The revenue fell largely because last year’s quarter included a large one-time system sale, while this year’s quarter is building a much bigger forward pipeline. In practical terms, D-Wave looks less like a company struggling to find demand and more like a company whose revenue recognition is simply uneven because of how these contracts land.
The second reason D-Wave stands out is strategic. The acquisition of Quantum Circuits changed the company’s profile materially. D-Wave is no longer just an annealing story. It now calls itself the first dual-platform quantum company, pairing its already-commercial Advantage2 annealing systems with an error-corrected gate-model roadmap, including plans to make an initial gate-model system available in 2026.
That matters because it expands the addressable market. If D-Wave had remained only an annealing company, investors could fairly argue that it occupied an interesting but narrow corner of quantum. The gate-model acquisition changes that. It gives the company a path into the broader quantum conversation while keeping its strongest current advantage: it is one of the few names in the space that can already point to deployed commercial systems and real customers.
The risk is still obvious. This is a volatile, high-beta company with lumpy revenue and heavy spending. But if the sector is going to reward a smaller-cap name for actual traction, D-Wave has one of the strongest claims.
IBM is the most credible large-cap quantum exposure on the board
IBM (NYSE: IBM) belongs on this list for the opposite reason.
This is not the most explosive name in the sector. It is the one with the deepest institutional credibility, the clearest technical roadmap, and the least dependence on quantum hype alone. IBM says it expects quantum advantage by the end of 2026 and has laid out a roadmap to Starling, its first large-scale fault-tolerant quantum computer, targeted for 2029 with 200 logical qubits and 100 million gates. It is also preparing Nighthawk, a 120-qubit processor intended to explore more complex circuits and help push the platform toward that advantage milestone.
That roadmap matters because IBM is doing something most of the sector still struggles to do: it is telling investors not just what it wants to build, but when, where, and how it expects to get there. The company is building Starling in Poughkeepsie, New York, and has been unusually public about the intermediate technical steps required to get there.
IBM also has the ecosystem to make the roadmap matter. Its quantum platform says it is trusted by 300+ clients and partners, and the IBM Quantum Network lists 300+ members, including industry clients, academic institutions, startups, and research hubs.
That ecosystem is a major part of the thesis. Quantum is not just a hardware race. It is also a software, developer, and application-discovery race. IBM’s advantage is that it has spent years building the platform, the network, and the customer relationships around the hardware. That makes IBM the easiest name on this list to defend in a professional portfolio context.
The trade-off is that IBM will never give you the same torque as a pure-play small cap if the sector catches fire. But if you want exposure to the space without betting everything on a fragile balance sheet or a binary commercialization event, IBM is probably the highest-quality way to own the theme.
QUBT is the highest-risk name here — and that is exactly why it matters
Then there is Quantum Computing Inc. (Nasdaq: QUBT).
This is the most speculative name on the list. But it is also the one where the market can rerate the story the fastest if execution keeps improving.
The headline catalyst is the quarter. QUBT reported Q1 2026 revenue of $3.7 million, up from just $39 thousand a year ago, and ended the quarter with about $1.4 billion in cash, cash equivalents, and investments. Management also highlighted the completed acquisitions of Luminar Semiconductor and NuCrypt, which it says improve its path to scalable manufacturing and deepen its quantum communications and photonics stack.
That revenue increase needs to be read correctly. It was driven primarily by the Luminar Semiconductor acquisition, and to a lesser extent NuCrypt, so this is not a clean organic hypergrowth story. But that does not make it unimportant. It tells you the company is trying to build a more substantial operating platform rather than remain a tiny conceptual science stock indefinitely.
The reason QUBT stays interesting is that it is not trying to win the same race as IBM. It is building around quantum optics, integrated photonics, and adjacent infrastructure where the commercial path may be different from the pure gate-model players. Management is explicitly positioning the company around lower-power, room-temperature photonic systems and high-growth end markets such as AI, cybersecurity, aerospace and defense, and advanced sensing.
That gives the stock a different kind of optionality. If IBM is the platform incumbent and D-Wave is the pure-play commercial quantum name, QUBT is the speculative architecture-and-adjacency play. It has the highest execution risk of the three, but also the most room for a narrative and valuation rerating if investors start believing the photonics strategy is becoming commercially real.
Why we are choosing these three
These are not random picks. They cover the three most important ways to express a bullish view on the sector right now.
D-Wave is on the list because it has the clearest combination of commercial traction, large new bookings, and a broadened product roadmap. The company is no longer only selling a story. It is selling systems, signing contracts, and building forward backlog.
IBM is on the list because it is the most credible scaled player in the space. The roadmap is real, the ecosystem is real, and the balance sheet is not dependent on quantum succeeding tomorrow morning. That makes it the best institutional-grade quantum exposure on the board.
QUBT is on the list because it offers a different kind of upside: a photonics-centered, high-risk, small-cap story with fresh revenue growth, major cash, and enough recent corporate activity to keep investors engaged. It is not the safest name — it is the one with the most speculative upside if execution lands.
The real sector call
The bigger point is that quantum is no longer just a novelty trade. It is becoming a strategic computing sector with enough capital, enough customer activity, and enough roadmap visibility to matter.
That does not mean investors should pretend commercialization risk has disappeared. But sectors do not need to be finished to be investable. They need to show that the pieces are getting serious. In quantum, those pieces are starting to line up.
WSA Take
Quantum computing still belongs in the speculative bucket. But it is no longer a blind speculation bucket.
If you want the pure-play commercial angle, D-Wave has the strongest near-term operating catalysts. If you want the highest-quality long-duration exposure, IBM is the name that looks most institutionally credible. If you want the smaller-cap upside shot with the most torque, QUBT is the one that can move hardest if the company keeps turning photonics ambition into something more tangible.
That is the real setup here: one sector, three very different ways to be bullish.
Disclaimer
WallStAccess is a financial media platform providing market commentary and analysis for informational and educational purposes only. This content does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers should conduct their own research or consult a licensed financial professional before making investment decisions.
